Profile data is unavailable for this security.
About the company
Microbot Medical Inc. is a pre-clinical medical device company. The Company is specializing in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is primarily focused on leveraging its robotic technologies with surgical robotics to improve surgical outcomes for patients. Its technological platforms include LIBERTY and NovaCross. Using its LIBERTY Endovascular Robotic Surgical System, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. LIBERTY Endovascular Robotic Surgical System addresses the needs of interventional cardiology, interventional radiology and interventional neuroradiology markets.
- Revenue in USD (TTM)0.00
- Net income in USD-10.44m
- Incorporated1988
- Employees22.00
- LocationMicrobot Medical Inc25 RECREATION PARK DR SUITE 108HINGHAM 02043United StatesUSA
- Phone+1 (908) 938-5561
- Fax+1 (302) 655-5049
- Websitehttp://www.microbotmedical.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor Therapeutics Inc | 0.00 | -3.02m | 14.65m | 3.00 | -- | 3.54 | -- | -- | -0.0175 | -0.0175 | 0.00 | 0.024 | 0.00 | -- | -- | 0.00 | -34.83 | 27.48 | -34.99 | 32.70 | -- | -- | -- | -- | -- | -- | 0.00 | 0.00 | -- | -- | -125.39 | -- | -- | -- |
| Eom Pharmaceutical Holdings Inc | 0.00 | -4.93m | 15.18m | 3.00 | -- | -- | -- | -- | -0.0435 | -0.0435 | 0.00 | -0.0212 | -- | -- | -- | 0.00 | -- | -126.34 | -- | -171.37 | -- | -- | -- | -- | -- | -- | 7.41 | -- | -- | -- | -254.37 | -- | -- | -- |
| AIM ImmunoTech Inc | 201.00k | -28.05m | 15.29m | 26.00 | -- | 2.25 | -- | 76.07 | -0.5703 | -0.5703 | 0.004 | 0.1068 | 0.0082 | -- | 12.18 | 7,730.77 | -113.70 | -45.64 | -149.16 | -48.35 | 71.14 | -231.75 | -13,952.74 | -11,695.01 | -- | -- | 0.3018 | -- | 43.26 | -11.26 | -48.94 | -- | 35.73 | -- |
| Sol Gel Technologies Ltd | 6.56m | -14.92m | 15.50m | 36.00 | -- | 0.4441 | -- | 2.36 | -0.5354 | -0.5354 | 0.2355 | 1.25 | 0.1351 | -- | 1.59 | 182,194.40 | -30.72 | -31.60 | -34.59 | -35.49 | -- | -- | -227.40 | -135.76 | -- | -- | 0.00 | -- | -59.98 | 64.50 | -82.52 | -- | -33.78 | -- |
| Minerva Neurosciences Inc | 0.00 | -3.31m | 16.15m | 9.00 | -- | -- | -- | -- | -0.4357 | -0.4357 | 0.00 | -3.10 | 0.00 | -- | -- | 0.00 | -6.25 | -49.89 | -6.75 | -52.39 | -- | -- | -- | -442.65 | -- | -- | -- | -- | -- | -- | 6.55 | -- | -- | -- |
| IN8BIO, Inc. | 0.00 | -31.96m | 16.37m | 31.00 | -- | 1.19 | -- | -- | -0.8357 | -0.8357 | 0.00 | 0.2933 | 0.00 | -- | -- | 0.00 | -122.41 | -74.18 | -146.35 | -84.42 | -- | -- | -- | -- | -- | -- | 0.0945 | -- | -- | -- | -5.21 | -- | -4.54 | -- |
| Tenax Therapeutics Inc | 0.00 | -12.57m | 16.70m | 5.00 | -- | 1.08 | -- | -- | -22.35 | -22.35 | 0.00 | 4.53 | 0.00 | -- | -- | 0.00 | -101.95 | -199.16 | -113.79 | -285.64 | -- | -- | -- | -- | -- | -95.94 | 0.0305 | -- | -- | -- | 30.21 | -- | -- | -- |
| Synlogic Inc | 3.17m | -56.16m | 17.08m | 6.00 | -- | 1.07 | -- | 5.39 | -7.24 | -7.24 | 0.3549 | 1.37 | 0.0628 | -- | -- | 528,333.30 | -111.31 | -40.57 | -131.17 | -43.82 | -- | -- | -1,771.74 | -3,245.93 | -- | -- | 0.00 | -- | 185.68 | 5.99 | 13.40 | -- | -48.05 | -- |
| Microbot Medical Inc | 0.00 | -10.44m | 17.10m | 22.00 | -- | 2.66 | -- | -- | -0.81 | -0.81 | 0.00 | 0.3793 | 0.00 | -- | -- | 0.00 | -113.94 | -53.28 | -133.34 | -62.65 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 18.44 | -- | -31.76 | -- |
| Traws Pharma Inc | 226.00k | -137.05m | 17.85m | 16.00 | -- | -- | -- | 78.98 | -138.17 | -138.17 | 0.2557 | 6.03 | 0.0092 | -- | 12.91 | 14,125.00 | -557.63 | -63.43 | -896.39 | -85.72 | -- | -- | -60,641.15 | -3,257.92 | -- | -- | 0.00 | -- | 0.00 | -28.72 | 0.0844 | -- | -- | -- |
| Cocrystal Pharma Inc | 0.00 | -17.93m | 17.91m | 12.00 | -- | 1.03 | -- | -- | -1.76 | -1.76 | 0.00 | 1.71 | 0.00 | -- | -- | 0.00 | -61.98 | -50.94 | -66.88 | -52.77 | -- | -- | -- | -1,501.78 | -- | -- | 0.00 | -- | -- | -- | 53.69 | -- | 33.34 | -- |
| Lyra Therapeutics Inc | 1.82m | -101.39m | 18.00m | 87.00 | -- | 0.5811 | -- | 9.89 | -1.61 | -1.61 | 0.0294 | 0.4733 | 0.0165 | -- | -- | 20,681.82 | -92.07 | -58.01 | -108.51 | -68.69 | -- | -- | -5,570.88 | -6,235.31 | -- | -- | 0.00 | -- | 14.31 | 4.60 | -13.39 | -- | 95.14 | -- |
| Finch Therapeutics Group Inc | 0.00 | -14.17m | 18.47m | 18.00 | -- | 1.30 | -- | -- | -8.82 | -8.82 | 0.00 | 8.86 | 0.00 | -- | -- | -- | -25.20 | -- | -28.80 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -87.57 | -- | 34.80 | -- | -- | -- |
| Aprea Therapeutics Inc | 1.31m | -13.51m | 18.64m | 7.00 | -- | 0.8494 | -- | 14.22 | -2.81 | -2.81 | 0.2646 | 4.28 | 0.0498 | -- | -- | 187,262.90 | -51.30 | -68.66 | -60.22 | -77.19 | -- | -- | -1,030.42 | -42,112.84 | -- | -- | 0.00 | -- | -- | -- | 87.32 | -- | 90.61 | -- |
| NanoViricides Inc | 0.00 | -8.29m | 18.83m | 7.00 | -- | 1.55 | -- | -- | -0.698 | -0.698 | 0.00 | 0.8722 | 0.00 | -- | -- | 0.00 | -55.81 | -43.88 | -59.61 | -46.26 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 3.43 | -- | 16.23 | -- |
| Promis Neurosciences Inc | 0.00 | -12.20m | 19.73m | 6.00 | -- | -- | -- | -- | -0.6924 | -0.6924 | 0.00 | -0.1201 | 0.00 | -- | -- | 0.00 | -839.15 | -144.28 | -- | -262.23 | -- | -- | -- | -2,271,047.00 | -- | -- | -- | -- | -- | -- | 26.85 | -- | -- | -- |
Data as of Nov 13 2024. Currency figures normalised to Microbot Medical Inc's reporting currency: US Dollar USD
6.31%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Jun 2024 | 456.58k | 2.77% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 137.38k | 0.83% |
| Geode Capital Management LLCas of 30 Jun 2024 | 119.94k | 0.73% |
| Contego Capital Group, Inc.as of 30 Jun 2024 | 100.00k | 0.61% |
| Alphacentric Advisors LLCas of 30 Sep 2024 | 100.00k | 0.61% |
| Renaissance Technologies LLCas of 30 Jun 2024 | 29.30k | 0.18% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 26.07k | 0.16% |
| PlainsCapital Bank (Investment Management)as of 30 Jun 2024 | 25.44k | 0.15% |
| Thoroughbred Financial Services LLCas of 30 Sep 2024 | 25.00k | 0.15% |
| Wells Fargo Clearing Services LLCas of 30 Jun 2024 | 21.28k | 0.13% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
